Economic methods for measuring the quality of life associated with HIV infection

Background: Quality of life is measured as utilities for cost-effectiveness analyses. Objective: To test the adequacy of three common utility elicitation methods for individuals with Human Immunodeficiency Virus (HIV) disease. Measurements: HIV-positive participants (n = 75) rated three standardized health states (symptomatic HIV infection, minor AIDS defining illness, and major AIDS defining illness) with two utility elicitation methods (Standard Gamble [SG], and Time Trade-off [TTO]) and one value method (Visual Analog [VA]). Participants also rated their own health with one utility method (Health Utilities Index [HUI]) and one conventional quality of life method (Medical Outcomes Study–HIV Health Survey [MOS-HIV]). Results: For all states, SG and TTO scores ranged from near 0.00 (equivalent to death) to 1.00 (best possible quality of life). Mean scores for symptomatic HIV were similar with the SG (0.80) and TTO (0.81) but higher than with the VA (0.70). Similar results were observed for minor AIDS defining illnesses (0.65, 0.65, 0.46 respectively) and major AIDS defining illnesses (0.42, 0.44, 0.25 respectively). Discrepant SG and TTO scores were observed in many individuals and were not explained by demographic characteristics. As expected, HUI scores of an individual's own health were related to the disease state. Four of ten MOS-HIV subscales (overall health, physical functioning, role functioning, and pain) were also related to disease state. HUI scores were correlated with the MOS-HIV score for overall health and for all MOS-HIV subscales except health transition. Conclusions: Mean utility scores for HIV-related health states elicited by the Standard Gamble and Time Trade-off were similar but a large degree of individual variation persists. Economic methods provide imprecise estimates of the quality of life associated with HIV infection.

[1]  I Grant,et al.  Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. , 1990, Journal of acquired immune deficiency syndromes.

[2]  A. Wu,et al.  The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison , 1996, Quality of Life Research.

[3]  A. Tversky,et al.  The framing of decisions and the psychology of choice. , 1981, Science.

[4]  J. R. Bult,et al.  Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patients. , 1998, Medical care.

[5]  A. Wu,et al.  Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) , 1997, Quality of Life Research.

[6]  W. Grove.  Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[7]  D A Revicki,et al.  Change in clinical status, health status, and health utility outcomes in HIV-infected patients. , 1995, Medical care.

[8]  R. F. Nease,et al.  Physicians' assessments of the utility of health states associated with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) Infection , 2004, Quality of Life Research.

[9]  L. Markson,et al.  The AIDS-defining diagnosis and subsequent complications: a survival-based severity index. , 1991, Journal of acquired immune deficiency syndromes.

[10]  B. Everitt,et al.  Statistical methods for rates and proportions , 1973 .

[11]  D A Redelmeier,et al.  Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. , 1992, Journal of clinical epidemiology.

[12]  F. J. Fowler,et al.  The Role of Reluctance to Give Up life in the Measurement of the Values of Health states , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  R L Kane,et al.  Methodology for measuring health-state preferences--I: Measurement strategies. , 1989, Journal of clinical epidemiology.

[14]  D. Lamping.  Methods for measuring outcomes to evaluate interventions to improve health-related quality of life in HIV infection , 1994 .

[15]  H. Rubin,et al.  A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection , 1991, Medical care.

[16]  M. Weinstein,et al.  Identifying and Valuing Outcomes , 1996 .

[17]  D. Kanouse,et al.  Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. , 1995, Medical care.

[18]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[19]  D. Feeny,et al.  Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. , 1996, Medical care.

[20]  G W Torrance,et al.  Utility approach to measuring health-related quality of life. , 1987, Journal of chronic diseases.

[21]  R L Kane,et al.  Methodology for measuring health-state preferences--III: Population and context effects. , 1989, Journal of clinical epidemiology.

[22]  D. Feeny,et al.  Utilities and Quality-Adjusted Life Years , 1989, International Journal of Technology Assessment in Health Care.

[23]  P. Dolan,et al.  Valuing health states: a comparison of methods. , 1996, Journal of health economics.

[24]  A. Tversky,et al.  On the elicitation of preferences for alternative therapies. , 1982, The New England journal of medicine.

[25]  H. Kunreuther,et al.  Sources of Bias in Assessment Procedures for Utility Functions , 1982 .

[26]  George W. Torrance,et al.  Social preferences for health states: An empirical evaluation of three measurement techniques , 1976 .

[27]  M C Weinstein,et al.  Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. , 1996, Medical care.

[28]  G W Torrance,et al.  Multi-attribute preference functions. Health Utilities Index. , 1995, PharmacoEconomics.

[29]  R. Gulick.  Current antiretroviral therapy: an overview , 1997, Quality of Life Research.

[30]  A. Wu,et al.  Assessment of quality of life in HIV disease , 1994 .

[31]  H. Sacks,et al.  Cost‐effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testing , 1997, AIDS.

[32]  J. Hall,et al.  Framing and labelling effects in health descriptions: quality adjusted life years for treatment of breast cancer. , 1993, Journal of clinical epidemiology.

[33]  A. Mocroft,et al.  Staging system for clinical AIDS patients , 1995, The Lancet.

[34]  A. Detsky,et al.  A clinician's guide to cost-effectiveness analysis. , 1990, Annals of internal medicine.

[35]  R. Kane,et al.  Methodology for measuring health-state preferences--II: Scaling methods. , 1989, Journal of clinical epidemiology.

[36]  R Tibshirani,et al.  Describing Health States: Methodologic Issues in Obtaining Values for Health States , 1984, Medical care.

[37]  J. de Haes,et al.  Utility Assessment in Cancer Patients , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[38]  S. Shumaker,et al.  Assessing health-related quality of life in HIV disease: key measurement issues , 1997, Quality of Life Research.

[39]  D. Matchar,et al.  Assessing quality of life and preferences in the seriously ill using utility theory. , 1990, Journal of clinical epidemiology.

[40]  G W Torrance,et al.  Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.

[41]  D. Owens,et al.  Occupational exposure to human immunodeficiency virus and hepatitis B virus: a comparative analysis of risk. , 1992, The American journal of medicine.

[42]  D R Holtgrave,et al.  Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[43]  H. Fineberg,et al.  Preferences for Health Outcomes , 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

[44]  E. Nord,et al.  Methods for quality adjustment of life years. , 1992, Social science & medicine.

[45]  Donald A. Redelmeier,et al.  Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost‐effectiveness analysis , 1998, AIDS.